What Shengtong Intelligent Technology does

Shengtong Intelligent Technology is a private, Beijing-headquartered company whose firmographic profile describes it as focused on artificial intelligence digital medical platforms. First-party sources associated with the entity (ST N Technologies Limited, stnpath.com, registered in Richmond, CA) present a digital pathology and laboratory services business serving biopharmaceutical research, drug discovery, and pre-clinical sample testing customers. The offering combines laboratory services (slide preparation, digital scanning, IHC/ISH and histopathology) with digital histology services (AI analysis and algorithm services), and is delivered through three software platforms: a Laboratory Animal Breeding System providing closed-loop management of experimental animal breeding; a Digital Pathology Auxiliary Analysis System built on Whole Slide Imaging (WSI) technology; and a Digital Slice Management System described as proprietary-intellectual-property-protected intelligent image analysis.

The business model is enterprise B2B software and services to life sciences customers; pricing is not publicly disclosed. The company raised a tens-of-millions CNY financing round in 2025, reported 300% revenue growth in H1 2025 versus the entire prior year, and is reported to have received orders from SoftBank and Transsion for smart glasses products. This latter activity sits in tension with the pathology product portfolio and appears, based on the input's own commentary, to reflect an entity-confusion between the smart glasses venture (associated with former Gionee core founders) and ST N Technologies Limited. The company has no disclosed management team, headcount, or geographic footprint beyond the Beijing parent and a US contact presence.

Grounded only in the provided sources: the company's verifiable identity is a small, early-stage AI-enabled pathology software and laboratory services vendor that has recently raised growth capital and is reporting triple-digit revenue growth, while one source block describes a separate or potentially conflated smart glasses business with named enterprise customers.

Name

Shengtong Intelligent Technology

Legal name

ST N Technologies Limited

Website

https://staitech.cn

Company type

Private

Founded year

2021

Operating status

Operating

Short description

Beijing-based private AI software company developing digital pathology, laboratory animal breeding, and digital slice management platforms for biopharmaceutical research, drug discovery, and pre-clinical sample testing customers in the life sciences sector.

Ownership category

akta.pro rank

Product category

Digital Pathology Software

NAICS

Medical and Diagnostic Laboratories (62151), Software Publishers (5132)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

akta.pro secondary industries

Imaging/Lab Integration & Results Management (PACS, LIS Connectivity, Reporting) (HLAMAGAK), Clinical Decision Support & Workflow Automation (Protocols, Templates, AI Scribing) (HLAMAGAH)

Keywords

• Digital pathology software
• AI medical platforms
• Laboratory information systems
• Histopathology analysis
• Drug discovery services

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Core offering

Shengtong Intelligent Technology develops AI-powered digital pathology software platforms and provides supporting laboratory and digital histology services for biopharmaceutical research, drug discovery, and pre-clinical sample testing. Its three flagship software platforms are the Laboratory Animal Breeding System (closed-loop management of breeding, feeding, research, sales with full traceability), the Digital Pathology Auxiliary Analysis System (built on Whole Slide Imaging), and the Digital Slice Management System (proprietary-IP intelligent image analysis). Complementary services include slide preparation, digital scanning, IHC/ISH and histopathology, AI analysis, and algorithm services.

Product overview

ST N Technologies Limited offers laboratory and digital histology services and products. The company provides laboratory services including slide preparation, digital scanning, and in situ detection (IHC/ISH) and histopathology services. Their digital histology offerings include AI analysis and algorithm services. The product portfolio consists of three main software platforms: Laboratory Animal Breeding System (for managing experimental animal breeding operations), Digital Pathology Auxiliary Analysis System (using Whole Slide Imaging for digital pathology), and Digital Slice Management System (intelligent image analysis platform). The company focuses on AI-driven pathology solutions for biopharmaceutical research, drug discovery, and pre-clinical sample testing.

Differentiator

Problem solved

Functional benefit

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• Owkin: Owkin applies AI to medical research and pathology for biopharma drug discovery, with a broader portfolio across multiple therapeutic areas—comparable to ST N's pre-clinical AI pathology focus but at significantly larger scale.

Direct peers

• Ibex Medical Analytics: Ibex develops AI-based pathology solutions for cancer detection and clinical decision support, comparable to ST N's AI-driven tissue recognition and diagnostic support tools.
• Proscia: Proscia provides a digital pathology software platform with AI-ready workflows for research and clinical use, closely aligned with ST N's Digital Pathology Auxiliary Analysis and Digital Slice Management platforms.
• 3DHISTECH: 3DHISTECH provides whole slide scanning hardware and digital pathology software for clinical and research use, comparable to ST N's WSI-based digital pathology platform.
• Paige: Paige builds AI-driven digital pathology solutions for cancer diagnosis and biopharma, with FDA-authorized products. Directly comparable to ST N's whole slide imaging and AI analysis offerings for pathology.
• PathAI: PathAI develops AI-powered pathology software for both clinical diagnostics and biopharma research, directly comparable to ST N's digital pathology AI analysis platform targeting drug discovery and pre-clinical workflows.
• Visiopharm: Visiopharm offers AI-driven image analysis and workflow software for digital pathology, serving pharma and research customers—directly comparable to ST N's histopathology AI and lab workflow tools.
• Indica Labs: Indica Labs provides digital pathology image analysis software (HALO platform) used widely in pharma research and pre-clinical studies, directly comparable to ST N's AI analysis and digital slice management products.

Emerging players

• Aignostics: Aignostics builds AI-based pathology solutions for biopharma research, with a focus on foundation models for histopathology—comparable to ST N's AI-driven pathology analysis platform for drug discovery.

Regional players

• KFBIO (Konfoong Biotech): KFBIO is a leading Chinese digital pathology scanner and AI software provider serving China-based hospitals and research institutions, directly comparable to ST N as a regional competitor in the same geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shengtong Intelligent Technology